Kingdon Capital Management
New York City, New Yorkkingdon.com
Overview
Kingdon Capital Management is a US-based hedge fund manager founded in 1983 that employs global long/short equity and healthcare-focused investment strategies.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Sapience Therapeutics | May 2022 | Series B | Co-investor |
| CeQur | Apr 2021 | Series C Extension | Co-investor |
| Imago BioSciences | Nov 2020 | Series C | Co-investor |
| Gracell Bio | Feb 2019 | Series B | Lead |
| Mighty Therapeutics | Jun 2018 | Convertible Debt | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
